Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
VRWalk
A Multisite Randomized Clinical Trial to Examine the Efficacy and Mechanisms of Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury
3 other identifiers
interventional
250
2 countries
3
Brief Summary
The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 13, 2021
CompletedStudy Start
First participant enrolled
November 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
December 17, 2025
September 1, 2025
4.8 years
August 6, 2021
December 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity
The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.
Baseline - final follow up (up to 18 months)
Secondary Outcomes (6)
Change in Pain Quality
Baseline - final follow up (up to 18 months)
Change in Pain Interference
Baseline - final follow up (up to 18 months)
Post treatment change
at follow up (up to 18 months)
Change in mood
Baseline - final follow up (up to 18 months)
Change in quality of life
Baseline - final follow up (up to 18 months)
- +1 more secondary outcomes
Study Arms (2)
Virtual reality (VR) game 1
ACTIVE COMPARATORParticipants will be asked to play a virtual reality game twice a day for 10 days.
Virtual reality (VR) game 2
ACTIVE COMPARATORParticipants will be asked to play a virtual reality game twice a day for 10 days.
Interventions
Individuals playing VR game 1 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
Individuals playing VR game 2 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
Eligibility Criteria
You may qualify if:
- The study will recruit individuals with complete injury (American Spinal Injury Association \[ASIA\] classification A) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criteria will include:
- Must have persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months
- Must endorse more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI
- Must be 18 years of age or older
- Must be more than one year post-injury to begin study (can be screened at an earlier time for eligibility)
- Must have mobile connectivity with usable service
- Must be stable on pain medication for 1 or more months
- Must be cleared on the VRWalk physical activity clearance scale
- Must not have motion sickness that interferes with daily life
You may not qualify if:
- Individuals with Injury levels between C1 and C4
- Individuals under the age of 18
- Individuals who were injured within the past year
- Individuals who cannot comprehend spoken English
- Individuals who are in prison
- Individuals who are blind
- Individuals who experience severe motion sickness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Texas A&M Universitylead
- United States Department of Defensecollaborator
- Richmond VA Medical Centercollaborator
- Immersive Experience Labscollaborator
Study Sites (3)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Texas A&M University
College Station, Texas, 77843, United States
University of New South Wales
Sydney, New South Wales, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zina Trost, PhD
Texas A&M University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 13, 2021
Study Start
November 23, 2021
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
December 17, 2025
Record last verified: 2025-09